We are live on
!
Find out more
DM
Deerfield Management Portfolio holdings
AUM
$8.48B
1-Year Est. Return
99.04%
This Fund
S&P 500
This Quarter
Est. Return
+14.29%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.45B
AUM Growth
+$519M
(+27%)
Cap. Flow
-$25.5M
Cap. Flow
% of AUM
-1.04%
Top 10 Holdings %
Top 10 Hldgs %
32.76%
Holding
158
New
53
Increased
22
Reduced
25
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$90.2M |
| 2 |
Labcorp
LH
|
+$65.9M |
| 3 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
+$53.4M |
| 4 |
AbbVie
ABBV
|
+$51.8M |
| 5 |
ITMN
INTERMUNE INC
ITMN
|
+$35.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$43.2M |
| 2 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
+$41.1M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$37.6M |
| 4 |
Globus Medical
GMED
|
+$34.2M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.78% |
| 2 | Technology | 1.21% |
| 3 | Financials | 0.56% |
| 4 | Industrials | 0% |
Similar funds
FT
GRQ
PCM
VA
QC
IC
NW
AAF
Deerfield Management's Q1 2014 Portfolio in Review
As of Q1 2014, Deerfield Management held 158 positions worth $2.45B, up 27% from $1.93B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Deerfield Management's Q1 2014 filing shows 53 new, 22 increased, 25 reduced and 33 closed positions. Its largest new stake was Dicerna Pharmaceuticals, Inc.: 2,428,569 shares worth $68.6M. The largest sale was Humana, an estimated $43.2M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Technology and Financials.
- Deerfield Management's largest Q1 2014 buy was Dicerna Pharmaceuticals, Inc.: 2,428,569 shares worth $68.6M.
- Deerfield Management added most to Insmed in Q1 2014, an estimated $18.3M increase.
- Deerfield Management's biggest Q1 2014 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $41.1M.
- Deerfield Management fully exited Humana in Q1 2014, selling an estimated $43.2M.
- Deerfield Management's ten largest holdings make up 33% of its $2.45B portfolio in Q1 2014.
- Deerfield Management opened 53 new positions and closed 33 in Q1 2014.
- Deerfield Management's portfolio value rose 27% quarter-over-quarter to $2.45B.
Based on Deerfield Management's 13F filing for Q1 2014, filed 15 May 2014.